Baixar PDF
Artigo anterior
Voltar à página
Artigo seguinte
If you have problems to see the content please click here
Outros usuários também visualizaram estes artigos
Diagnosis and treatment of chronic lymphocytic leukemia: 2025 recommendations of the Brazilian Group of Chronic Lymphocytic Leukemia of the Brazilian Association of Hematology and Hemotherapy (ABHH)
Carlos Sérgio Chiattone; Fernanda de Morais Marques; Valeria Buccheri; Mihoko Yamamoto; Sergio Costa Fortier; Maura Rosane Valerio Ikoma-Colturato; Nelson Hamerschlak; Vera Lucia de Piratininga Figueiredo; Talita Maira Bueno da Silveira; Abel Costa; Dani Laks; Rony Schaffel; Wolney Gois Barreto; Adriana Scheliga; Pedro Amoedo Fernandes; Samir Kanaan Nabhan; Rafael Dezen Gaiolla; Matheus Vescovi Gonçalves; Danielle Leão Cordeiro de Farias; Glaciano Ribeiro; Marcelo Pitombeira de Lacerda; Celso Arrais-Rodrigues;
10.1016/j.htct.2025.103822
Patient-reported outcomes of treatment and adverse effects following acute lymphoblastic leukemia: a low- and middle-income country cross-sectional study
Eduardo Cerello Chapchap; Nina Melo; Denise Martins; Maria Lucia Lee; Nelson Hamerschlak;
Hematol Transfus Cell Ther. 2024;46 Supl 6:S182-92
Subcutaneous low-dose azacitidine as maintenance therapy following hematopoietic stem cell transplantation for acute myeloid leukemia and high-risk myelodysplastic syndrome¿A propensity score matched analysis
André Dias Américo; Cinthya Correa Silva; Mariana Nassif Kerbauy; Leonardo Javier Arcuri; Andressa Alice Feitosa Ribeiro; Nelson Hamerschlak; Fábio Pires Souza Santos;
Hematol Transfus Cell Ther. 2024;46 Supl 6:S427-30